Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shaughnessy

Showing results (81-90 of 194) with videos related to

Pageof 20
Sort By:
Cancers|February 12, 2021
Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and ProgressionCan Li, Erik B Wendlandt, Benjamin Darbro, et al.
British Journal of Haematology|February 28, 2008
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2Mauricio Pineda-Roman, Maurizio Zangari, Jeff Haessler, et al.
Blood Advances|March 1, 2023
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysisFarah Mazahreh, Liyan Mazahreh, Carolina Schinke, et al.
Blood|May 22, 2009
RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myelomaSiqing Wang, Guido Tricot, Lei Shi, et al.
The Journal of Urology|November 16, 2010
Prospective evaluation of operating characteristics of prostate cancer detection biomarkersYuanyuan Liang, Donna P Ankerst, Norma S Ketchum, et al.
Journal of Virology|November 1, 1995
Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomasB C Cho, J D Shaughnessy, D A Largaespada, et al.
British Journal of Haematology|April 25, 2009
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone diseaseAngela Pennisi, Xin Li, Wen Ling, et al.
Oncogene|May 13, 1999
Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1J D Shaughnessy, D A Largaespada, E Tian, et al.
Blood|March 14, 2008
An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myelomaWei Xiong, Xiaosong Wu, Sarah Starnes, et al.
Blood|July 26, 2014
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSarah K Johnson, James P Stewart, Rakesh Bam, et al.
Pageof 20

Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
Cancers|February 12, 2021
Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and ProgressionCan Li, Erik B Wendlandt, Benjamin Darbro, et al.
British Journal of Haematology|February 28, 2008
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2Mauricio Pineda-Roman, Maurizio Zangari, Jeff Haessler, et al.
Blood Advances|March 1, 2023
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysisFarah Mazahreh, Liyan Mazahreh, Carolina Schinke, et al.
Blood|May 22, 2009
RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myelomaSiqing Wang, Guido Tricot, Lei Shi, et al.
The Journal of Urology|November 16, 2010
Prospective evaluation of operating characteristics of prostate cancer detection biomarkersYuanyuan Liang, Donna P Ankerst, Norma S Ketchum, et al.
Journal of Virology|November 1, 1995
Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomasB C Cho, J D Shaughnessy, D A Largaespada, et al.
British Journal of Haematology|April 25, 2009
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone diseaseAngela Pennisi, Xin Li, Wen Ling, et al.
Oncogene|May 13, 1999
Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1J D Shaughnessy, D A Largaespada, E Tian, et al.
Blood|March 14, 2008
An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myelomaWei Xiong, Xiaosong Wu, Sarah Starnes, et al.
Blood|July 26, 2014
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseSarah K Johnson, James P Stewart, Rakesh Bam, et al.
Pageof 20